Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1991 May 25;302(6787):1224–1226. doi: 10.1136/bmj.302.6787.1224

Contraception.

A Szarewski, J Guillebaud
PMCID: PMC1669938  PMID: 2043843

Full text

PDF
1224

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson J. K., Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol. 1990 Aug;97(8):690–694. doi: 10.1111/j.1471-0528.1990.tb16240.x. [DOI] [PubMed] [Google Scholar]
  2. Buchan H., Villard-Mackintosh L., Vessey M., Yeates D., McPherson K. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use. Br J Obstet Gynaecol. 1990 Sep;97(9):780–788. doi: 10.1111/j.1471-0528.1990.tb02571.x. [DOI] [PubMed] [Google Scholar]
  3. Christian C. D. Maternal deaths associated with an intrauterine device. Am J Obstet Gynecol. 1974 Jun 15;119(4):441–444. doi: 10.1016/0002-9378(74)90198-7. [DOI] [PubMed] [Google Scholar]
  4. Cleland J. Cash payments for family planning in Bangladesh. IPPF Med Bull. 1990 Feb;24(1):3–4. [PubMed] [Google Scholar]
  5. Craig S., Hepburn S. The effectiveness of barrier methods of contraception with and without spermicide. Contraception. 1982 Oct;26(4):347–359. doi: 10.1016/0010-7824(82)90102-0. [DOI] [PubMed] [Google Scholar]
  6. Cramer D. W., Schiff I., Schoenbaum S. C., Gibson M., Belisle S., Albrecht B., Stillman R. J., Berger M. J., Wilson E., Stadel B. V. Tubal infertility and the intrauterine device. N Engl J Med. 1985 Apr 11;312(15):941–947. doi: 10.1056/NEJM198504113121502. [DOI] [PubMed] [Google Scholar]
  7. Croft P., Hannaford P. C. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study. BMJ. 1989 Jan 21;298(6667):165–168. doi: 10.1136/bmj.298.6667.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Daling J. R., Weiss N. S., Metch B. J., Chow W. H., Soderstrom R. M., Moore D. E., Spadoni L. R., Stadel B. V. Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med. 1985 Apr 11;312(15):937–941. doi: 10.1056/NEJM198504113121501. [DOI] [PubMed] [Google Scholar]
  9. Drife J. The benefits of combined oral contraceptives. Br J Obstet Gynaecol. 1989 Nov;96(11):1255–1258. doi: 10.1111/j.1471-0528.1989.tb03220.x. [DOI] [PubMed] [Google Scholar]
  10. Fischl M. A., Dickinson G. M., Scott G. B., Klimas N., Fletcher M. A., Parks W. Evaluation of heterosexual partners, children, and household contacts of adults with AIDS. JAMA. 1987 Feb 6;257(5):640–644. [PubMed] [Google Scholar]
  11. Fotherby K., Trayner I., Longthorne P. N., Lee B., Watson H. R. Metabolic investigations with Femodene--an oral contraceptive containing gestodene and ethinyloestradiol. Contraception. 1987 Apr;35(4):323–337. doi: 10.1016/0010-7824(87)90069-2. [DOI] [PubMed] [Google Scholar]
  12. Godsland I. F., Crook D., Simpson R., Proudler T., Felton C., Lees B., Anyaoku V., Devenport M., Wynn V. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med. 1990 Nov 15;323(20):1375–1381. doi: 10.1056/NEJM199011153232003. [DOI] [PubMed] [Google Scholar]
  13. Guillebaud J. Oral contraceptives in risk groups: exclusion or monitoring? Am J Obstet Gynecol. 1990 Jul;163(1 Pt 2):443–446. doi: 10.1016/0002-9378(90)90598-2. [DOI] [PubMed] [Google Scholar]
  14. Hammond G. L., Langley M. S., Robinson P. A., Nummi S., Lund L. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel. Fertil Steril. 1984 Jul;42(1):44–51. doi: 10.1016/s0015-0282(16)47956-2. [DOI] [PubMed] [Google Scholar]
  15. Hicks D. R., Martin L. S., Getchell J. P., Heath J. L., Francis D. P., McDougal J. S., Curran J. W., Voeller B. Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet. 1985 Dec 21;2(8469-70):1422–1423. doi: 10.1016/s0140-6736(85)92584-x. [DOI] [PubMed] [Google Scholar]
  16. Inman W. H., Vessey M. P., Westerholm B., Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J. 1970 Apr 25;2(5703):203–209. doi: 10.1136/bmj.2.5703.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jones W. R., Bradley J., Judd S. J., Denholm E. H., Ing R. M., Mueller U. W., Powell J., Griffin P. D., Stevens V. C. Phase I clinical trial of a World Health Organisation birth control vaccine. Lancet. 1988 Jun 11;1(8598):1295–1298. doi: 10.1016/s0140-6736(88)92117-4. [DOI] [PubMed] [Google Scholar]
  18. Kay C. R. The Royal College of General Practitioners' Oral Contraception Study: some recent observations. Clin Obstet Gynaecol. 1984 Dec;11(3):759–786. [PubMed] [Google Scholar]
  19. Kloosterboer H. J., Vonk-Noordegraaf C. A., Turpijn E. W. Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives. Contraception. 1988 Sep;38(3):325–332. doi: 10.1016/0010-7824(88)90104-7. [DOI] [PubMed] [Google Scholar]
  20. Lee N. C., Rubin G. L., Borucki R. The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study. Obstet Gynecol. 1988 Jul;72(1):1–6. [PubMed] [Google Scholar]
  21. Lee N. C., Rubin G. L., Ory H. W., Burkman R. T. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol. 1983 Jul;62(1):1–6. [PubMed] [Google Scholar]
  22. Lepot M. R., Gaspard U. J. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene. Int J Fertil. 1987;32 (Suppl):15–20. [PubMed] [Google Scholar]
  23. MacKenzie I. Z., Turner E., O'Sullivan G. M., Guillebaud J. Two hundred out-patient laparoscopic clip sterilizations using local anaesthesia. Br J Obstet Gynaecol. 1987 May;94(5):449–453. doi: 10.1111/j.1471-0528.1987.tb03124.x. [DOI] [PubMed] [Google Scholar]
  24. Malkovsky M., Newell A., Dalgleish A. G. Inactivation of HIV by nonoxynol-9. Lancet. 1988 Mar 19;1(8586):645–645. doi: 10.1016/s0140-6736(88)91440-7. [DOI] [PubMed] [Google Scholar]
  25. Mammen E. F. Oral contraceptives and blood coagulation: a critical review. Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):781–790. doi: 10.1016/s0002-9378(16)32489-9. [DOI] [PubMed] [Google Scholar]
  26. Mann J. I., Inman W. H. Oral contraceptives and death from myocardial infarction. Br Med J. 1975 May 3;2(5965):245–248. doi: 10.1136/bmj.2.5965.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Newton J., Tacchi D. Long-term use of copper intrauterine devices. A statement from the Medical Advisory Committee of the Family Planning Association and the National Association of Family Planning Doctors. Lancet. 1990 Jun 2;335(8701):1322–1323. doi: 10.1016/0140-6736(90)91198-j. [DOI] [PubMed] [Google Scholar]
  28. Nirapathpongporn A., Huber D. H., Krieger J. N. No-scalpel vasectomy at the King's birthday vasectomy festival. Lancet. 1990 Apr 14;335(8694):894–895. doi: 10.1016/0140-6736(90)90487-p. [DOI] [PubMed] [Google Scholar]
  29. Pardthaisong T., Gray R. H., McDaniel E. B. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand. Lancet. 1980 Mar 8;1(8167):509–512. doi: 10.1016/s0140-6736(80)92765-8. [DOI] [PubMed] [Google Scholar]
  30. Rabe T., Runnebaum B., Kohlmeier M., Harenberg J., Weicker H. Clinical and metabolic effects of gestodene and levonorgestrel. Int J Fertil. 1987;32 (Suppl):29–44. [PubMed] [Google Scholar]
  31. Rietmeijer C. A., Krebs J. W., Feorino P. M., Judson F. N. Condoms as physical and chemical barriers against human immunodeficiency virus. JAMA. 1988 Mar 25;259(12):1851–1853. [PubMed] [Google Scholar]
  32. Sachs B. P., Masterson T., Jewett J. F., Guyer B. Reproductive mortality in Massachusetts in 1981. N Engl J Med. 1984 Sep 6;311(10):667–670. doi: 10.1056/NEJM198409063111011. [DOI] [PubMed] [Google Scholar]
  33. Sivin I., Stern J., Diaz J., Diaz M. M., Faundes A., el Mahgoub S., Diaz S., Pavez M., Coutinho E., Mattos C. E. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices. Contraception. 1987 Mar;35(3):245–255. doi: 10.1016/0010-7824(87)90026-6. [DOI] [PubMed] [Google Scholar]
  34. Smith G. L., Smith K. F. Lack of HIV infection and condom use in licensed prostitutes. Lancet. 1986 Dec 13;2(8520):1392–1392. doi: 10.1016/s0140-6736(86)92028-3. [DOI] [PubMed] [Google Scholar]
  35. Stampfer M. J., Willett W. C., Colditz G. A., Speizer F. E., Hennekens C. H. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med. 1988 Nov 17;319(20):1313–1317. doi: 10.1056/NEJM198811173192004. [DOI] [PubMed] [Google Scholar]
  36. Tikkanen M. J., Nikkilä E. A. Oral contraceptives and lipoprotein metabolism. J Reprod Med. 1986 Sep;31(9 Suppl):898–905. [PubMed] [Google Scholar]
  37. Trap R., Trap B., Petersen C. S. Evaluation of the amount of nonoxynol available in condoms for the inhibition of HIV using a method based on HPLC. Int J STD AIDS. 1990 Sep;1(5):346–348. doi: 10.1177/095646249000100509. [DOI] [PubMed] [Google Scholar]
  38. Vessey M. P., Villard-Mackintosh L., McPherson K., Yeates D. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study. BMJ. 1989 Dec 16;299(6714):1487–1491. doi: 10.1136/bmj.299.6714.1487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Vessey M., Lawless M., Yeates D. Efficacy of different contraceptive methods. Lancet. 1982 Apr 10;1(8276):841–842. doi: 10.1016/s0140-6736(82)91885-2. [DOI] [PubMed] [Google Scholar]
  40. van der Vange N., Kloosterboer H. J., Haspels A. A. Effect of seven low-dose combined oral contraceptive preparations on carbohydrate metabolism. Am J Obstet Gynecol. 1987 Apr;156(4):918–922. doi: 10.1016/0002-9378(87)90355-3. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES